Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | calcium motive p-type ATPase, putative | 0.0099 | 0.037 | 1 |
Schistosoma mansoni | sodium/potassium-dependent atpase beta subunit | 0.0508 | 0.4097 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0259 | 0.1832 | 0.4412 |
Giardia lamblia | Potassium-transporting ATPase alpha chain 1 | 0.0259 | 0.1832 | 1 |
Trypanosoma brucei | calcium-translocating P-type ATPase | 0.0099 | 0.037 | 1 |
Brugia malayi | Calcium-transporting ATPase sarcoplasmic/endoplasmic reticulum type | 0.0099 | 0.037 | 0.2018 |
Echinococcus multilocularis | plasma membrane calcium transporting ATPase | 0.0099 | 0.037 | 0.083 |
Leishmania major | P-type ATPase, putative | 0.0099 | 0.037 | 1 |
Trichomonas vaginalis | plasma membrane calcium-transporting ATPase, putative | 0.0099 | 0.037 | 1 |
Schistosoma mansoni | transmemberane protein | 0.0508 | 0.4097 | 1 |
Echinococcus multilocularis | nervana 2 | 0.0508 | 0.4097 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0161 | 0.0936 | 0.22 |
Leishmania major | calcium-transporting ATPase, putative | 0.0099 | 0.037 | 1 |
Trypanosoma brucei | calcium motive p-type ATPase, putative | 0.0099 | 0.037 | 1 |
Echinococcus granulosus | plasma membrane calcium transporting ATPase 2 | 0.0099 | 0.037 | 0.083 |
Echinococcus granulosus | Ca2 transporting ATPase plasma membrane | 0.0099 | 0.037 | 0.083 |
Mycobacterium ulcerans | isocitrate lyase AceAb | 0.1157 | 1 | 1 |
Echinococcus multilocularis | sodium:potassium dependent atpase beta subunit | 0.0508 | 0.4097 | 1 |
Plasmodium vivax | P-type ATPase4, putative | 0.0099 | 0.037 | 0.5 |
Echinococcus granulosus | calcium transporting ATPase type 2C member | 0.0099 | 0.037 | 0.083 |
Echinococcus granulosus | sodium:potassium dependent atpase beta subunit | 0.0508 | 0.4097 | 1 |
Schistosoma mansoni | calcium-transporting atpase sarcoplasmic/endoplasmic reticulum type (calcium pump) | 0.0099 | 0.037 | 0.083 |
Schistosoma mansoni | na+/k+ atpase alpha subunit | 0.0259 | 0.1832 | 0.4428 |
Schistosoma mansoni | calcium-transporting atpase sarcoplasmic/endoplasmic reticulum type (calcium pump) | 0.0099 | 0.037 | 0.083 |
Echinococcus granulosus | nervana 2 | 0.0421 | 0.3298 | 0.8034 |
Entamoeba histolytica | Plasma membrane calcium-transporting ATPase, putative | 0.0089 | 0.0287 | 0.7755 |
Loa Loa (eye worm) | Na,K-ATPase alpha subunit | 0.0259 | 0.1832 | 0.4412 |
Echinococcus granulosus | plasma membrane calcium transporting ATPase | 0.0099 | 0.037 | 0.083 |
Trichomonas vaginalis | plasma membrane calcium-transporting ATPase, putative | 0.0099 | 0.037 | 1 |
Schistosoma mansoni | plasma membrane calcium-transporting atpase | 0.0099 | 0.037 | 0.083 |
Plasmodium vivax | calcium-transporting ATPase, putative | 0.0099 | 0.037 | 0.5 |
Schistosoma mansoni | Na+/K+ transporting ATPase subunit alpha | 0.0259 | 0.1832 | 0.4428 |
Loa Loa (eye worm) | hypothetical protein | 0.0508 | 0.4097 | 1 |
Echinococcus multilocularis | nervana 2 | 0.0421 | 0.3298 | 0.8034 |
Mycobacterium ulcerans | isocitrate lyase Icl | 0.1157 | 1 | 1 |
Entamoeba histolytica | Plasma membrane calcium-transporting ATPase, putative | 0.0089 | 0.0287 | 0.7755 |
Loa Loa (eye worm) | sodium/potassium-transporting ATPase subunit alpha | 0.0224 | 0.1506 | 0.3608 |
Plasmodium falciparum | non-SERCA-type Ca2+ -transporting P-ATPase | 0.0099 | 0.037 | 0.5 |
Trypanosoma brucei | vacuolar-type Ca2+-ATPase, putative | 0.0089 | 0.0287 | 0.7455 |
Trypanosoma cruzi | calcium motive p-type ATPase, putative | 0.0099 | 0.037 | 1 |
Echinococcus multilocularis | sodium:potassium dependent atpase beta subunit | 0.0421 | 0.3298 | 0.8034 |
Loa Loa (eye worm) | hypothetical protein | 0.0089 | 0.0287 | 0.06 |
Trypanosoma brucei | vacuolar-type Ca2+-ATPase 2 | 0.0089 | 0.0287 | 0.7455 |
Echinococcus multilocularis | Ca2+ transporting ATPase plasma membrane | 0.0099 | 0.037 | 0.083 |
Schistosoma mansoni | sodium / potassium ATPase beta chain | 0.0421 | 0.3298 | 0.8034 |
Loa Loa (eye worm) | hypothetical protein | 0.0508 | 0.4097 | 1 |
Toxoplasma gondii | P-type ATPase4, putative | 0.0099 | 0.037 | 1 |
Echinococcus multilocularis | calcium transporting atpase | 0.0099 | 0.037 | 0.083 |
Plasmodium falciparum | calcium-transporting ATPase | 0.0099 | 0.037 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0201 | 0.1305 | 0.3112 |
Trypanosoma cruzi | plasma membrane Ca2+ ATPase | 0.0089 | 0.0287 | 0.7455 |
Echinococcus multilocularis | Na+:K+ ATPase alpha subunit | 0.0259 | 0.1832 | 0.4428 |
Schistosoma mansoni | ATPase | 0.0089 | 0.0287 | 0.0626 |
Echinococcus granulosus | nervana 2 | 0.0508 | 0.4097 | 1 |
Echinococcus multilocularis | sodium:potassium transporting ATPase subunit | 0.0508 | 0.4097 | 1 |
Echinococcus multilocularis | sarco:endoplasmic reticulum calcium ATPase | 0.0089 | 0.0287 | 0.0626 |
Toxoplasma gondii | sarco/endoplasmic reticulum Ca2+-ATPase | 0.0099 | 0.037 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0174 | 0.1053 | 0.2491 |
Echinococcus granulosus | Na:K ATPase alpha subunit | 0.0259 | 0.1832 | 0.4428 |
Schistosoma mansoni | plasma membrane calcium-transporting atpase | 0.0099 | 0.037 | 0.083 |
Entamoeba histolytica | Plasma membrane calcium-transporting ATPase, putative | 0.0089 | 0.0287 | 0.7755 |
Echinococcus granulosus | nervana 2 | 0.0508 | 0.4097 | 1 |
Mycobacterium leprae | Isocitrate lyase | 0.0542 | 0.4408 | 0.348 |
Mycobacterium tuberculosis | Probable isocitrate lyase AceAa [first part] (isocitrase) (isocitratase) (Icl) | 0.1157 | 1 | 0.5 |
Echinococcus multilocularis | calcium transporting ATPase type 2C member | 0.0099 | 0.037 | 0.083 |
Mycobacterium tuberculosis | Isocitrate lyase Icl (isocitrase) (isocitratase) | 0.1157 | 1 | 0.5 |
Trypanosoma cruzi | plasma membrane Ca2+ ATPase | 0.0089 | 0.0287 | 0.7455 |
Brugia malayi | Probable calcium-transporting ATPase KIAA0703 | 0.0063 | 0.0044 | 0.0238 |
Echinococcus granulosus | sodium:potassium dependent atpase beta subunit | 0.0421 | 0.3298 | 0.8034 |
Schistosoma mansoni | ATPase | 0.0089 | 0.0287 | 0.0626 |
Mycobacterium tuberculosis | Probable isocitrate lyase AceAb [second part] (isocitrase) (isocitratase) (Icl) | 0.1157 | 1 | 0.5 |
Toxoplasma gondii | plasma membrane-type Ca(2+)-ATPase A1 PMCAA1 | 0.0099 | 0.037 | 1 |
Schistosoma mansoni | calcium-transporting atpase 2 (atpase 2) | 0.0099 | 0.037 | 0.083 |
Onchocerca volvulus | 0.0421 | 0.3298 | 0.6596 | |
Echinococcus granulosus | sarco:endoplasmic reticulum calcium ATPase | 0.0089 | 0.0287 | 0.0626 |
Echinococcus granulosus | sodium:potassium dependent atpase beta subunit | 0.0508 | 0.4097 | 1 |
Trypanosoma cruzi | Calcium ATPase SERCA-like | 0.0089 | 0.0287 | 0.7455 |
Mycobacterium ulcerans | metal cation transporter p-type ATPase a | 0.025 | 0.1749 | 0.1432 |
Echinococcus multilocularis | sodium:potassium dependent atpase beta subunit | 0.0508 | 0.4097 | 1 |
Trypanosoma cruzi | calcium motive p-type ATPase, putative | 0.0099 | 0.037 | 1 |
Echinococcus multilocularis | nervana 2 | 0.0508 | 0.4097 | 1 |
Echinococcus granulosus | nervana 2 | 0.0421 | 0.3298 | 0.8034 |
Brugia malayi | Membrane calcium atpase protein 3 | 0.0099 | 0.037 | 0.2018 |
Entamoeba histolytica | calcium-transporting P-type ATPase, putative | 0.0099 | 0.037 | 1 |
Echinococcus granulosus | sodium:potassium transporting ATPase subunit | 0.0508 | 0.4097 | 1 |
Echinococcus granulosus | calcium transporting atpase | 0.0099 | 0.037 | 0.083 |
Echinococcus multilocularis | Tetracycline resistance leader peptide, TetL | 0.0099 | 0.037 | 0.083 |
Trypanosoma brucei | vacuolar-type Ca2+-ATPase 1 | 0.0089 | 0.0287 | 0.7455 |
Brugia malayi | Sodium/potassium-transporting ATPase alpha chain, putative | 0.0224 | 0.1506 | 0.822 |
Schistosoma mansoni | sodium/potassium-dependent atpase beta subunit | 0.0508 | 0.4097 | 1 |
Echinococcus multilocularis | nervana 2 | 0.0421 | 0.3298 | 0.8034 |
Schistosoma mansoni | sodium/potassium-dependent atpase beta subunit | 0.0421 | 0.3298 | 0.8034 |
Brugia malayi | Na,K-ATPase alpha subunit | 0.0259 | 0.1832 | 1 |
Onchocerca volvulus | 0.0508 | 0.4097 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.